Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 709

1.

An open-label trial of risperidone augmentation for refractory anxiety disorders.

Simon NM, Hoge EA, Fischmann D, Worthington JJ, Christian KM, Kinrys G, Pollack MH.

J Clin Psychiatry. 2006 Mar;67(3):381-5.

PMID:
16649823
2.

Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.

Katzman MA, Vermani M, Jacobs L, Marcus M, Kong B, Lessard S, Galarraga W, Struzik L, Gendron A.

J Anxiety Disord. 2008 Dec;22(8):1480-6. doi: 10.1016/j.janxdis.2008.03.002. Epub 2008 Mar 13.

PMID:
18455360
3.

Adjunctive risperidone in generalized anxiety disorder: a double-blind, placebo-controlled study.

Brawman-Mintzer O, Knapp RG, Nietert PJ.

J Clin Psychiatry. 2005 Oct;66(10):1321-5.

PMID:
16259547
4.

Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).

Vieta E, Herraiz M, Fernández A, Gastó C, Benabarre A, Colom F, Martínez-Arán A, Reinares M.

J Clin Psychiatry. 2001 Aug;62(8):623-30.

PMID:
11561935
5.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
6.

Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.

Gao K, Muzina D, Gajwani P, Calabrese JR.

J Clin Psychiatry. 2006 Sep;67(9):1327-40. Review.

PMID:
17017818
7.

Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.

Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE Jr, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.

J Affect Disord. 2009 Jun;115(3):376-85. doi: 10.1016/j.jad.2008.10.005. Epub 2008 Nov 29.

PMID:
19042026
8.
9.

An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.

Hirschfeld RM, Eerdekens M, Kalali AH, Canuso CM, Khan AA, Karcher K, Palumbo JM.

Int Clin Psychopharmacol. 2006 Jan;21(1):11-20.

PMID:
16317312
10.

An open-label study of levetiracetam for the treatment of social anxiety disorder.

Simon NM, Worthington JJ, Doyle AC, Hoge EA, Kinrys G, Fischmann D, Link N, Pollack MH.

J Clin Psychiatry. 2004 Sep;65(9):1219-22.

PMID:
15367048
11.

Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.

Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH.

J Clin Psychiatry. 2008 Apr;69(4):520-5.

PMID:
18278987
12.

Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder.

Davidson JR, Bose A, Wang Q.

J Clin Psychiatry. 2005 Nov;66(11):1441-6.

PMID:
16420082
13.

Open-label risperidone for Asperger's disorder: negative symptom spectrum response.

Rausch JL, Sirota EL, Londino DL, Johnson ME, Carr BM, Bhatia R, Miller S.

J Clin Psychiatry. 2005 Dec;66(12):1592-7.

PMID:
16401163
14.

Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder.

Hoge EA, Worthington JJ 3rd, Kaufman RE, Delong HR, Pollack MH, Simon NM.

CNS Spectr. 2008 Jun;13(6):522-7.

PMID:
18567977
15.

A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.

Adams JB, Pyke RE, Costa J, Cutler NR, Schweizer E, Wilcox CS, Wisselink PG, Greiner M, Pierce MW, Pande AC.

J Clin Psychopharmacol. 1995 Dec;15(6):428-34.

PMID:
8748432
16.
17.

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.

Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.

Depress Anxiety. 2008;25(3):182-9.

PMID:
17311303
18.

Levetiracetam for treatment-refractory posttraumatic stress disorder.

Kinrys G, Wygant LE, Pardo TB, Melo M.

J Clin Psychiatry. 2006 Feb;67(2):211-4.

PMID:
16566615
19.

An open-label trial of nefazodone in high comorbidity panic disorder.

DeMartinis NA, Schweizer E, Rickels K.

J Clin Psychiatry. 1996 Jun;57(6):245-8.

PMID:
8666561

Supplemental Content

Support Center